RNA interference of caveolin-1 via lentiviral vector inhibits growth of hypopharyngeal squamous cell carcinoma FaDu cells in vitro and in vivo

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 2, 2011, Pages 397-401

  Zhao, Xuening ^a   Ma, Chao ^a   Cai, Xiaolan ^a   Lei, Dapeng ^a   Liu, Dayu ^a   Xu, Fenglei ^a   Jin, Tong ^a   Liu, Jun ^a   Pan, Xinliang ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Caveolin 1; Hypopharyngeal carcinoma cells; Lentivirus; RNA interference

Indexed keywords

EID: 79958813868     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Anderson RG. (1998). The caveolae membrane system. Annu Rev Biochem, 67, 199-225.
2. Belanger MM, Roussel E, Couet J. (2004). Caveolin-1 is downregulated in human lung carcinoma and acts as a candidate tumor suppressor gene. Chest, 125, 106S.
3. Bender FC, Reymond MA, Bron C, et al. (2000). Caveolin-1 levels are down-regulated in human colon tumors, and ectopic expression of caveolin-1 in colon carcinoma cell lines reduces cell tumorigenicity. Cancer Res, 60, 5870-8.
4. Chen ST, Lin SY. Yeh KT, et al. (2004). Mutational, epigenetic and expressional analyses of caveolin-1 gene in breast cancers. Int J Mol Med, 14, 577-82.
5. Egloff AM, Rothstein ME, Seethala R, et al. (2009). Cross-talk between estrogen receptor and epidermal growth factor receptor in head and neck squamous cell carcinoma. Clin Cancer Res, 15, 6529-40.
6. Engelman JA, Wykoff CC, Yasuhara S, et al. (1997). Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth. J Biol Chem, 272, 16374-81.
7. Guo J, Zuo L, Liu J, et al. (2010). You have free access to this contentEffect of P38 MAPK on the apoptosis of human lung adenocarcinoma cell induced by the spider venom. Thoracic Cancer, 1, 77-82.
8. Kato K, Hida Y, Miyamoto M, et al. (2002). Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Cancer, 94, 929-33.
9. Kato T, Miyamoto M, Kato K, et al. (2004). Difference of caveolin-1 expression pattern in human lung neoplastic tissue. Atypical adenomatous hyperplasia, adenocarcinoma and squamous cell carcinoma. Cancer lett, 214, 121-8.
10. Lee SW, Reimer CL, Oh P, et al. (1998). Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells. Oncogene, 16, 1391-7.
11. Li L, Yang G, Ebara S, et al. (2001). Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells. Cancer Res, 61, 4386-92.
12. Lu ML, Schneider MC, Zheng Y, et al. (2001). Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation. J Biol Chem, 276, 13442-51.
13. Montgomery MK, Xu S, Fire A. (1998). RNA as a target of double-stranded RNA-mediated genetic interference in Caenorhabditis elegans. Proc Natl Acad Sci USA, 95, 15502-7.
14. Nishikura K. (2001). A short primer on RNAi: RNA-directed RNA polymerase acts as a key catalyst. Cell, 107, 415-8.
15. Orlandi PA, Fishman PH. (1998). Filipin-dependent inhibition of cholera toxin: evidence for toxin internalization and activation through caveolae-like domains. J Cell Biol, 141, 905-15.
16. Park JS, Kim HY, Kim HW, et al. (2005a). Increased caveolin-1, a cause for the declined adipogenic potential of senescent human mesenchymal stem cells. Mech Ageing Dev, 126, 551-9.
17. Park SS, Kim JE, Kim YA, et al. (2005b). Caveolin-1 is downregulated and inversely correlated with HER2 and EGFR expression status in invasive ductal carcinoma of the breast. Histopathology, 47, 625-30.
18. Pike LJ. (2006). Rafts defined: a report on the Keystone Symposium on Lipid Rafts and Cell Function. J Lipid Res, 47, 1597-8.
19. Pike LJ, Han X, Chung KN, et al. (2002). Lipid rafts are enriched in arachidonic acid and plasmenylethanolamine and their composition is independent of caveolin-1 expression: a quantitative electrospray ionization/mass spectrometric analysis. Biochemistry, 41, 2075-88.
20. Rothberg KG, Heuser JE, Donzell WC. (1992). Caveolin, a protein component of caveolae membrane coats. Cell, 68, 673-82.
21. Sharp PA. (2001). RNA interference--2001. Genes Devel, 15, 485-90.
22. Sinicrope FA, Ruan SB, Cleary KR, et al. (1995). bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res, 55, 237-41.
23. Smart EJ, Graf GA, McNiven MA, et al. (1999). Caveolins, liquid-ordered domains, and signal transduction. Mol Cell Biol, 19, 7289-304.
24. Sonveaux P, Martinive P, DeWever J, et al. (2004). Caveolin-1 expression is critical for vascular endothelial growth factorinduced ischemic hindlimb collateralization and nitric oxidemediated angiogenesis. Circ Res, 95, 154-61.
25. Suzuoki M, Miyamoto M, Kato K, et al. (2002). Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma. Br J Cancer, 87, 1140-4.
26. Wiechen K, Diatchenko L, Agoulnik A, et al. (2001a). Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene. Am J Pathol, 159, 1635-43.
27. Wiechen K, Sers C, Agoulnik A, et al. (2001b). Down-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomas. Am J Pathol, 158, 833-9.
28. Woodman SE, Ashton AW, Schubert W, et al. (2003). Caveolin-1 knockout mice show an impaired angiogenic response to exogenous stimuli. Am J Pathol, 162, 2059-68.
29. Yamada E. (1955). The fine structure of the gall bladder epithelium of the mouse. J Biophys Biochem Cytol, 1, 445-58.
30. Yang G, Truong LD, Wheeler TM, et al. (1999). Caveolin-1 expression in clinically confined human prostate cancer: a novel prognostic marker. Cancer Res, 59, 5719-23.